AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11398117
Drug: Nitazoxanide 100
RxNorm normalized name: nitazoxanide 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitazoxanide 100 mg twice daily for 3 days (children aged 1-3 years)
Trial: 21907749
Drug: MVA-B (1×10(8)
RxNorm normalized name: amphotericin B 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVA-B (1×10(8) pfu/dose) administered as 3 intramuscular injections at weeks 0, 4, and 16
Trial: 21907749
Drug: MVA-B (1×10(8)
RxNorm normalized name: amphotericin B 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVA-B (1×10(8) pfu/dose)
Trial: 10700784
Drug: Intrathecal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal bupivacaine 1.25 mg and fentanyl 25 micrograms (group A)
Trial: 10700784
Drug: Intrathecal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal bupivacaine 2.5 mg and fentanyl 25 micrograms (group B)
Trial: 7537364
Drug: High-dose methotrexate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methotrexate therapy
Trial: 2037113
Drug: GnRH‐a and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH‐a and hMG for IVF treatment with extended follicle growth by 1 day
Trial: 7125264
Drug: Midazolam-Ketamine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam-Ketamine combination (0.15 mg/kg midazolam and 0.75 mg/kg ketamine)
Trial: 30882604
Drug: Firibastat (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Firibastat (250 mg b.i.d. for 1 week, uptitrated to 500 mg b.i.d. for 3 weeks)
Trial: 28555206
Drug: Conical connection
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conical connection implants
Trial: 28555206
Drug: Internal hex
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internal hex connection implants
Trial: 26686406
Drug: Elotuzumab 10
RxNorm normalized name: elotuzumab
DrugBank: Elotuzumab (DB06317)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Elotuzumab 10 mg/kg plus lenalidomide (25 mg) and dexamethasone (40 mg)
Trial: 26686406
Drug: Elotuzumab 20
RxNorm normalized name: elotuzumab
DrugBank: Elotuzumab (DB06317)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Elotuzumab 20 mg/kg plus lenalidomide (25 mg) and dexamethasone (40 mg)
Trial: 19747744
Drug: Celecoxib (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (2 x 400 mg/day)
Trial: 12626436
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human IL-6 infusion (3 hours)
Trial: 11298543
Drug: Famciclovir (FCV)
RxNorm normalized name: Famciclovir
DrugBank: Famciclovir (DB00426)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Famciclovir (FCV) 125 mg twice daily for 5 days
Trial: 11298543
Drug: Aciclovir (ACV)
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aciclovir (ACV) 200 mg five times daily for 5 days
Trial: 8497826
Drug: Frusemide (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide (5, 10, and 20 mg)
Trial: 2447411
Drug: SLOx (slow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SLOx (slow release oxprenolol) administered in a single evening dose for 7 days
Trial: 2447411
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered for 7 days
Trial: 21178422
Drug: Procalcitonin (PCT)
RxNorm normalized name: Procalcitonin
DrugBank: Procalcitonin (DB14812)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procalcitonin (PCT) guidance for antibiotic therapy
Trial: 18005195
Drug: Enteral nutrition
RxNorm normalized name: ENTERAL NUTRITION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral nutrition (EG) - 3 cups of Clinutren fruit, 2 boxes of OPD Elemental 028 extra, 2 cups of OPD Peptamen, 1000 ml isotonic cristalloid solution, allowed to drink up to 1000 ml of tea or water per 24 h
Trial: 18005195
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition (PG) - 1250 ml Nutriflex lipid basal intravenously, 1000 ml isotonic cristalloid solution, allowed to drink up to 1000 ml of tea or water per 24 h
Trial: 18005195
Drug: Parenteral nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral nutrition (PG)
Trial: 350232
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg daily
Trial: 350232
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg daily
Trial: 30757926
Drug: Cervicothoracic junction
RxNorm normalized name: stannous fluoride
DrugBank: Stannous fluoride (DB11092)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cervicothoracic junction manual therapy
Trial: 30757926
Drug: Upper-cervical manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upper-cervical manual therapy
Trial: 19370038
Drug: Flaxseed lignan
RxNorm normalized name: FLAXSEED
DrugBank: Flax seed (DB10708)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed lignan complex (543 mg/day in a 4050 mg complex)
Trial: 12860938
Drug: Pemetrexed 500
RxNorm normalized name: pemetrexed 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed 500 mg/m2 and cisplatin 75 mg/m2
Trial: 10670374
Drug: Self-instructional module
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-instructional module (SIM) on care of child receiving Oxygen Therapy
Trial: 2568663
Drug: Minor tranquilizer
RxNorm normalized name: Vinca minor extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minor tranquilizer
Trial: 358760
Drug: Pindolol once
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pindolol once daily
Trial: 358760
Drug: Pindolol twice
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pindolol twice daily
Trial: 27498443
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amoxicillin and metronidazole (for 7 days)
Trial: 17900989
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training (a combination of aerobic and resistance training, three times per week for 24 weeks)
Trial: 14587010
Drug: Blood-pool contrast
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood-pool contrast media (NC100150, 2 ml/kg body weight)
Trial: 8708369
Drug: Aerosolized pentamidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized pentamidine (300 mg/4 weeks)
Trial: 8708369
Drug: Orally trimethoprim‐sulfamethoxazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally trimethoprim‐sulfamethoxazole (320‐1600 mg/day)
Trial: 1752294
Drug: Aspirin 300
RxNorm normalized name: aspirin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 300 mg three times a day (t.d.s.)
Trial: 1752294
Drug: Aspirin 300
RxNorm normalized name: aspirin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 300 mg three times a day (t.d.s.) with dipyridamole 100 mg t.d.s.
Trial: 7235320
Drug: Flunisolide intranasal
RxNorm normalized name: Flunisolide
DrugBank: Flunisolide acetate (DB14662)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flunisolide intranasal solution (200 microgram/day) combined with intrabronchial flunisolide (1 mg/day)
Trial: 7235320
Drug: Flunisolide intranasal
RxNorm normalized name: Flunisolide
DrugBank: Flunisolide acetate (DB14662)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flunisolide intranasal solution (200 microgram/day) combined with beclomethasone dipropionate bronchial aerosol (400 microgram/day)
Trial: 28494850
Drug: Traditional Persian
RxNorm normalized name: PERUVIAN BALSAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Persian medicine preparation of Alcea digitata and Malva sylvestris
Trial: 17467203
Drug: E2/DRSP (estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2/DRSP (estradiol 1 mg/drospirenone 2 mg)
Trial: 8093363
Drug: d4T (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d4T (2 mg/kg/day)
Trial: 9361572
Drug: Continuous intravenous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous intravenous heparin
Trial: 3531862
Drug: Intermittent subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent subcutaneous heparin
Trial: 30280654
Drug: Wearable cardioverter-defibrillator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wearable cardioverter-defibrillator plus guideline-directed therapy
Trial: 30280654
Drug: Guideline-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline-directed therapy only (control group)
Trial: 26663817
Drug: DHEA (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA (25 mg three times a day for 12 weeks)
Trial: 25591511
Drug: Traditional medicinal
RxNorm normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional medicinal treatment
Trial: 22460067
Drug: Maintenance dose
RxNorm normalized name: Firmagon 80mg Powder for Injection Maintenance Dose Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance dose of 50 μg
Trial: 22460067
Drug: Maintenance dose
RxNorm normalized name: Firmagon 80mg Powder for Injection Maintenance Dose Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance dose of 100 μg
Trial: 18174779
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II receptor blocker-based program
Trial: 18174779
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blocker-based treatment regimen
Trial: 18174779
Drug: Multiple-drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple-drug therapy (therapy with > or =2 medications)
Trial: 12872679
Drug: Cetirizine (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine (daily treatment for 3 years)
Trial: 12872679
Drug: Placebo (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (daily treatment for 3 years)
Trial: 7587910
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid ethyl (EPA-E) 900 mg/day
Trial: 120541
Drug: Alcohol (1
RxNorm normalized name: POLYVINYL ALCOHOL (18000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (1 g/kg in orange juice)
Trial: 120541
Drug: Alcohol (1
RxNorm normalized name: POLYVINYL ALCOHOL (18000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (1 g/kg in orange juice) plus CBD (200 mg capsule)
Trial: 120541
Drug: CBD (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBD (200 mg capsule)
Trial: 120541
Drug: Placebo (glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (glucose capsule and orange juice)
Trial: 25567214
Drug: Gabapentin 500
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin 500 mg
Trial: 22679719
Drug: Shencao Tongmai
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shencao Tongmai Granule (STG) plus Western medicine (WM) treatment
Trial: 22679719
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus Western medicine (WM) treatment
Trial: 9809893
Drug: Bivalirudin (direct
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalirudin (direct thrombin inhibitor)
Trial: 2490827
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment for hypertension (including thiazide-like diuretic agents)
Trial: 946209
Drug: Rabies vaccine
RxNorm normalized name: RABIES VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabies vaccine produced in human diploid cell culture (WI-38)
Trial: 946209
Drug: Rabies vaccine
RxNorm normalized name: RABIES VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabies vaccine produced in hamster kidney-cell culture
Trial: 7377574
Drug: Naloxone, 8
RxNorm normalized name: Buprenorphine-Naloxone, 8 mg-2 mg sublingual film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone, 8 mg
Trial: 7377574
Drug: Naloxone, 4
RxNorm normalized name: Buprenorphine-Naloxone, 4 mg-1 mg sublingual film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone, 4 mg
Trial: 26733360
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Treatment for Insomnia (CBT-I) followed by Positive Airway Pressure (PAP)
Trial: 26733360
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Treatment for Insomnia (CBT-I) and Positive Airway Pressure (PAP) administered concurrently
Trial: 24742739
Drug: Everolimus (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Everolimus (5 mg/day) plus trastuzumab (2 mg/kg) and vinorelbine (25 mg/m(2))
Trial: 17924890
Drug: Topical lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical lidocaine 2% combined with general anaesthesia
Trial: 9568921
Drug: First trimester
RxNorm normalized name: Cow first milk
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First trimester other illicit drug use
Trial: 2197635
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 1 g xantinolnicotinate (Complamin)
Trial: 320808
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg of 2% plain prilocaine
Trial: 320808
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg of 2% plain mepivacaine
Trial: 12843161
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate (200 mg)
Trial: 10983343
Drug: Oxytocin (parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin (parenteral administration)
Trial: 1583340
Drug: Ivermectin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin (1 mg clearing dose followed by either one or two 200 micrograms/kg doses)
Trial: 1583340
Drug: Diethylcarbamazine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diethylcarbamazine (12 daily 6 mg/kg doses)
Trial: 3905392
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II infusion (7.5 ng X kg‐1 X min‐1)
Trial: 3905392
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution infusion (control)
Trial: 30597550
Drug: Parent-mediated treatment
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent-mediated treatment
Trial: 29694316
Drug: Mindfulness-based stress
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based stress reduction (MBSR) + Treatment as Usual (TAU)
Trial: 26444907
Drug: Calcipotriene 0.005%
RxNorm normalized name: CALCIPOTRIENE 0.005% OINT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment
Trial: 18499730
Drug: Acute intra-arterial
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Acute intra-arterial vitamin C administration (24 mg min(‐1))
Trial: 18499730
Drug: Chronic oral
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic oral vitamin C supplementation (500 mg day(‐1))
Trial: 12915645
Drug: Biphasic association
RxNorm normalized name: HEPATITIS ASSOCIATED ANTIBODY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biphasic association of 40/30 micro g ethinyl estradiol (EE) and 25/125 micro g desogestrel (DSG)
Trial: 12915645
Drug: Monophasic association
RxNorm normalized name: Monobasic Potassium Phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monophasic association of 35 micro g EE and 2 mg cyproterone acetate (CPA)
Trial: 11382647
Drug: Daily disposable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily disposable contact lenses
Trial: 8906382
Drug: Conventional daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional daily wear contact lenses
Trial: 1796228
Drug: DEC 6
RxNorm normalized name: Zodryl DEC 60 Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEC 6 mg/kg
Trial: 6191906
Drug: 1 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g/day ISO for 7 days
Trial: 6191906
Drug: 4 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g/day ISO for 7 days
Trial: 6191906
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment for 7 days
Trial: 30772754
Drug: Intravenous Immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Immunoglobulin (IVIG)
Trial: 24485800
Drug: Modafinil (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (200 mg) combined with cognitive training
Trial: 22409711
Drug: UVA1 (moderate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UVA1 (moderate dose)
Trial: 22409711
Drug: UVA1 (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UVA1 (low dose)
Trial: 22409711
Drug: UVA1 (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UVA1 (both doses)
Trial: 12171430
Drug: TML liquid
RxNorm normalized name: BTL-TML-COVID
DrugBank: Thimerosal (DB11590)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TML liquid diet (20 g/d)
Trial: 12171430
Drug: Soybean oil
RxNorm normalized name: Soybean Oil
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soybean oil liquid diet (20 g/d)
Trial: 9854601
Drug: DDAVP plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DDAVP plus behavioral therapy
Trial: 9854601
Drug: Behavioral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral therapy plus placebo
Trial: 8570776
Drug: Naltrexone 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 40 mg
Trial: 1319874
Drug: Cimetidine 400mg
RxNorm normalized name: CIMETIDINE 400MG TAB
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine 400mg 3 times daily for 8 days
Trial: 6370028
Drug: Diazepam (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (10-20 mg)
Trial: 6370028
Drug: Triflupromazin (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triflupromazin (10-20 mg)
Trial: 6370028
Drug: Pethidin (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidin (50-100 mg)
Trial: 6370028
Drug: Buprenorphin (0.15-0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphin (0.15-0.3 mg)
Trial: 6370028
Drug: Droperidol (2.5-5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol (2.5-5 mg)
Trial: 22035500
Drug: Small-bowel capsule
RxNorm normalized name: Smallpox (Vaccinia) Vaccine, Live
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small-bowel capsule endoscopy
Trial: 22035500
Drug: Adequate antiallergic
RxNorm normalized name: Adequan
DrugBank: Polysulfated glycosaminoglycan (DB11538)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adequate antiallergic treatment
Trial: 17490956
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (6 g EPA+DHA/d) for either 7, 14, or 21 days before surgery
Trial: 17490956
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (10 mL/d for 21 days before surgery)
Trial: 17490956
Drug: Olive oil
RxNorm normalized name: Olive Oil
DrugBank: Olive oil (DB09567)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olive oil (10 mL/d for 21 days before surgery)
Trial: 11966665
Drug: Tezosentan infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tezosentan infusion at 100 mg h(‐1) for 6 h (study A)
Trial: 11966665
Drug: Tezosentan infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tezosentan infusion at 5 mg h(‐1) for 72 h (study B)
Trial: 9150773
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% with adrenaline (30 ml)
Trial: 9150773
Drug: Saline (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (30 ml)
Trial: 3440106
Drug: Erythromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (500 mg three times daily for 10 days)
Trial: 3440106
Drug: Control state
RxNorm normalized name: CLOZAPINE (GOLDEN STATE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control state (single dose of CBZ 400 mg)
Trial: 29462657
Drug: Serlopitant 1
RxNorm normalized name: Serlopitant
DrugBank: Serlopitant (DB12973)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serlopitant 1 mg
Trial: 27914504
Drug: Ezetimibe (Ez)
RxNorm normalized name: Ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ezetimibe (Ez) 10 mg/d with Simvastatin (S) 40 mg/d (Ez/S)